Immunic
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$93,612,000 over the previous period. Total operating expenses were $99,223,000.

Profit Margin

Immunic, Inc. (NASDAQ:IMUX): Profit margin
2014 0 -47.66M
2015 0 -52.02M
2016 0 -40.96M
2017 0 -52.07M
2018 0 -41.47M
2019 0 -34.82M
2020 0 -43.95M
2021 0 -92.79M
2022 0 -154.29M
2023 0 -93.61M

IMUX Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
0000000000
Cost of revenue
111K77K85K39K50K0998K01.32M0
Gross profit
-111K-77K-85K-39K-50K0-998K0-1.32M0
Operating exp.
Research and development
83.21M71.25M61.11M38.63M22.51M24.82M39.34M30.04M39.77M39.47M
Selling and marketing
0000000000
Total operating expenses
99.22M86.51M91.66M48.97M37.03M38.41M52.65M41.26M52.12M50.34M
Operating income
-99.22M-119.48M-91.66M-48.97M-37.03M-42.02M-52.65M-41.26M-52.12M-50.34M
Other income (expenses), net
5.61M-919K-1.28M4.95M2.09M-3.58M577K297K97K2.67M
Income before tax
-93.61M-120.40M-92.94M-44.01M-34.93M-41.47M-52.07M-40.96M-52.02M-47.66M
Income tax expense
033.88M-151K-58K-107K549K-577K-1.80M-1.32M-1.08M
Net income
-93.61M-154.29M-92.79M-43.95M-34.82M-41.47M-52.07M-40.96M-52.02M-47.66M
Earnings per share
Basic EPS
-2.11-4.85-3.92-2.81-4.51-39.16-52.26-52.21-82.73-80.01
Diluted EPS
-2.11-4.85-3.92-2.81-4.51-39.16-52.26-52.21-82.73-80.01
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source